Oncology May 2010
A Review of Glioblastoma Multiforme
This form of cancer is the most deadly of all brain tumors.
Newly Approved Agents for the Treatment of Myelodysplastic Syndromes
Myelodysplastic syndromes are a heterogeneous group of clonal
bone-marrow disorders characterized by ineffective hematopoiesis
resulting in blood cytopenias (anemia, neutropenia, and
thrombocytopenia).
Continuing Education
$7.95 Per CE Exam or $69 for 12 Lessons
-
• April 2026 • 2.00 Credits
Managing HIV Coinfections and Complications
-
Pain Management • March 2026 • 2.00 Credits
Updated Guidance for Opioid Use in Pain Management
-
Cardiovascular • February 2026 • 2.00 Credits
Managing Modifiable Risk Factors in Chronic Coronary Disease
Copyright © 2000 - 2024 Jobson Medical Information LLC unless otherwise noted. All rights reserved. Reproduction in whole or in part without permission is prohibited.